NaTrue certification for Dusoran and Cholesterol NF
Dishman has obtained the NaTrue label for natural like ingredients for its cosmetic raw material products Dusoran and Cholesterol NF.
Dishman has obtained the NaTrue label for natural like ingredients for its cosmetic raw material products Dusoran and Cholesterol NF.
Dishman is one of the first companies in Europe to obtain NATRUE certification for our cosmetic raw materials Dusoran and Cholesterol NF. This was obtained after having been audited at our production site in Veenendaal in the Netherlands.
NaTrue is an International Association of Natural and Organic Cosmetic manufacturers who aim to safeguard the highest possible standards for natural cosmetics and their ingredients in Europe but also in the United States and in the longer term also in Asia.
PRODUCT INFORMATION:
A) CHOLESTEROL NF
Cholesterol exists naturally in the human skin. It is our natural protection against outside influences such as dehydration and it regulates the transdermal transport of molecules. The usage of Cholesterol enhances the natural barrier of skin. It both moisturizes and contributes to the health of the skin. Cremes and lotions benefit from a shiny surface as cholesterol forms liquid crystals during formulation.
B) DUSORAN
Dusoran is ideal for hair colorants, hair conditioners, hair treatment (relaxing and perming), 2 in 1 hair combination products etc. In skincare applications, Dusoran can be used in both facial and body care.
To see a full list of Dishman Vitamins and Chemicals please go to:
http://www.dishmangroup.com/vitamins-chemicals.asp
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
